CoChat

Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation

Open access
Shah, Surbhi, Norby, Faye L., Datta, Yvonne H., Lutsey, Pamela L., MacLehose, Richard F., Chen, Lin Y., Alonso, Alvaro · 2018 · Blood Advances
Cited by 173

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Key Points: In AF and cancer patients, rate of bleeding is lower with apixaban, similar in dabigatran and rivaroxaban users, compared to warfarin users. Ischemic stroke rates did not differ among anticoagulant users. Incident VTE risk was lower in all DOAC compared with warfarin users.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/bloodadvances.2017010694

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 21

  1. Timp, 2013, Epidemiology of cancer-associated venous thrombosis, Blood, 122, 1712, 10.1182/blood-2013-04-460121 · DOI · Paper page
  2. Prandoni, 2002, Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis, Blood, 100, 3484, 10.1182/blood-2002-01-0108 · DOI · Paper page
  3. Lee, 2013, Treatment of cancer-associated thrombosis, Blood, 122, 2310, 10.1182/blood-2013-04-460162 · DOI · Paper page
  4. Hendrie, 2013, Are new oral anticoagulants ready for use in patients with cancer?, J Natl Compr Canc Netw, 11, 1446, 10.6004/jnccn.2013.0165 · doi:10.6004/jnccn.2013.0165
  5. Lyman, 2015, Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014, J Clin Oncol, 33, 654, 10.1200/JCO.2014.59.7351 · DOI · Paper page
  6. Jensen, 2012, A systematic review of validated methods for identifying atrial fibrillation using administrative data, Pharmacoepidemiol Drug Saf, 21, 141, 10.1002/pds.2317 · DOI · Paper page
  7. Garg, 2011, Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data, Pharmacoepidemiol Drug Saf, 20, 313, 10.1002/pds.2041 · DOI
  8. Andrade, 2012, A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data, Pharmacoepidemiol Drug Saf, 21, 100, 10.1002/pds.2312 · DOI · Paper page
  9. Cunningham, 2011, An automated database case definition for serious bleeding related to oral anticoagulant use, Pharmacoepidemiol Drug Saf, 20, 560, 10.1002/pds.2109 · DOI · Paper page
  10. Wahl, 2010, Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population, Pharmacoepidemiol Drug Saf, 19, 596, 10.1002/pds.1924 · DOI · Paper page
  11. Cushman, 2004, Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology, Am J Med, 117, 19, 10.1016/j.amjmed.2004.01.018 · DOI · Paper page
  12. White, 1998, Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California, Ann Intern Med, 128, 737, 10.7326/0003-4819-128-9-199805010-00006 · DOI · Paper page
  13. Heckbert, 2004, Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women’s Health Initiative, Am J Epidemiol, 160, 1152, 10.1093/aje/kwh314 · DOI · Paper page
  14. Kniffin, 1994, The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly, Arch Intern Med, 154, 861, 10.1001/archinte.1994.00420080053005 · doi:10.1001/archinte.1994.00420080053005 · Paper page
  15. Dombkowski, 2009, Asthma surveillance using Medicaid administrative data: a call for a national framework, J Public Health Manag Pract, 15, 485, 10.1097/PHH.0b013e3181a8c334 · doi:10.1097/phh.0b013e3181a8c334
  16. Rassen, 2011, Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples, Am J Epidemiol, 173, 1404, 10.1093/aje/kwr001 · DOI · Paper page
  17. Farmakis, 2014, Insights into onco-cardiology: atrial fibrillation in cancer, J Am Coll Cardiol, 63, 945, 10.1016/j.jacc.2013.11.026 · DOI · Paper page
  18. Khorana, 2007, Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy, J Thromb Haemost, 5, 632, 10.1111/j.1538-7836.2007.02374.x · DOI · Paper page
  19. Agnelli, 2015, Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial, J Thromb Haemost, 13, 2187, 10.1111/jth.13153 · DOI · Paper page
  20. Sardar, 2015, New oral anticoagulants in patients with cancer: current state of evidence, Am J Ther, 22, 460, 10.1097/MJT.0000000000000055 · DOI
  21. Streiff, 2016, Thrombosis in the setting of cancer, Hematology Am Soc Hematol Educ Program, 2016, 196, 10.1182/asheducation-2016.1.196 · DOI

Cited by

See all 173

Metadata

Authors
Shah, S., Norby, F. L., Datta, Y. H., Lutsey, P. L., MacLehose, R. F., Chen, L. Y., & Alonso, A.
Venue
Blood Advances
Published
2018-01-29
Volume
2
Issue
3
Pages
200-209
ISSN
  • 2473-9529 (ISSN-L)
  • 2473-9537
OpenAlex
W2787309434
Cited by
173
References
8
FWCI
15.83
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation. https://app.cochat.ai/papers/10.1182/bloodadvances.2017010694
The paper
Shah, S., Norby, F. L., Datta, Y. H., Lutsey, P. L., MacLehose, R. F., Chen, L. Y., & Alonso, A. (2018). Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation. Blood Advances. https://doi.org/10.1182/bloodadvances.2017010694

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.